ID   CX
AC   CVCL_C8XF
DR   Wikidata; Q123031149
RX   PubMed=8603367;
RX   PubMed=35692560;
CC   Population: Chinese; Taiwan.
CC   Doubling time: ~20 hours (PubMed=8603367).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
CC   Cell type: Epithelial cell of uterus; CL=CL_0002149.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=8603367; DOI=10.1016/0304-3835(96)04157-2;
RA   Chou, Cheng-Yang
RA   Chen, Yen-Hui
RA   Tzeng, Ching-Cherng
RA   Cheng, Yueh-Chin
RA   Chang, Chin-Feng
RA   Chen, Tzer-Ming
RT   "Establishment and characterization of a human-papillomavirus
RT   negative, p53-mutation negative human cervical cancer cell line.";
RL   Cancer Lett. 102:173-181(1996).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez, Ma
RA   Lopez-Mendoza, Carlos Miguel
RA   Tenorio-Salazar, Jared
RA   Garcia-Carranca, Alejandro Manuel
RA   Cerbon-Cervantes, Marco Antonio
RA   Alcantara-Quintana, Luz Eugenia
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//